Whitebox Advisors’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.3K Hold
152,500
﹤0.01% 504
2025
Q4
$47.3K Hold
152,500
﹤0.01% 389
2025
Q3
$44.2K Hold
152,500
﹤0.01% 336
2025
Q2
$38.2K Hold
152,500
﹤0.01% 309
2025
Q1
$30.5K Buy
+152,500
New +$26.8K ﹤0.01% 240

Other funds holding TDACW

Whitebox Advisors's TDACW Position: Q1 2026 in Review

Whitebox Advisors held its Translational Development Acquisition Corp Warrants (TDACW) position steady in Q1 2026 at 152,500 shares worth $18.3K. The position accounts for ﹤0.01% of the portfolio, ranked #504.

Whitebox Advisors first reported a position in TDACW in Q1 2025 and has held it in 5 quarters since. The position peaked at $47.3K in Q4 2025. 32 funds tracked by Wall St. Rank hold TDACW as of Q1 2026.

  • Whitebox Advisors held 152,500 shares of Translational Development Acquisition Corp Warrants worth $18.3K as of Q1 2026.
  • Whitebox Advisors left its Translational Development Acquisition Corp Warrants share count unchanged in Q1 2026.
  • Translational Development Acquisition Corp Warrants made up ﹤0.01% of Whitebox Advisors's portfolio in Q1 2026, its #504 holding.
  • Whitebox Advisors first reported a position in Translational Development Acquisition Corp Warrants in Q1 2025 and has held it in 5 quarters since.
  • Whitebox Advisors's Translational Development Acquisition Corp Warrants position peaked at $47.3K in Q4 2025.
  • 32 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q1 2026.

Based on Whitebox Advisors's 13F filing for Q1 2026, filed 15 May 2026.